Desmopressin EP Impurity E arises from synthetic variation or minor degradation of desmopressin. Such structural changes influence disulfide topology, polarity, and chromatographic behavior. Researchers use it as a reference for impurity quantification. Applications include stability analysis, synthetic-route verification, and peptide-quality assessment.
CAT No: R2782
Synonyms/Alias:N5,4-[(Acetylamino)methyl]desmopressin;(S)-1-((4R,7S,10S,13S,16S)-10-(3-acetamido-3-oxopropyl)-7-(2-amino-2-oxoethyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-N-((R)-1-((2-amino-2-oxoethyl)amino)-5-guanidino-1-oxopentan-2-yl)pyrrolidine-2-
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
2. Emu oil in combination with other active ingredients for treating skin imperfections
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.